Bacteriophage nanoparticles: an emerging modular delivery platform
Current Opinion in Biotechnology · 2026
DOI: 10.1016/j.copbio.2026.103527 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Opinion in Biotechnology, 2026. Verfasst von Linzi Whiley und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Natural Sciences, Macquarie University, Sydney, NSW 2109, Australia. Hauptthemen laut MEDLINE: Bacteriophages, Nanoparticles, Drug Delivery Systems. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council.
Abstract (Originalsprache)
Nanoparticles are now central to many drug and vaccine delivery strategies, but most require reformulation for each application. Bacteriophage‑derived nanoparticles offer a genetically encoded, structurally defined, and modular alternative. This review organizes recent advances along three tunable axes - scaffold, surface, and cargo - and highlights hybrid phage-polymer/lipid/inorganic constructs that expand stability, targeting, and loading. We survey applications from multivalent vaccines and oversized gene transfer to precision microbiome editing, and outline translational hurdles. Phage-derived products are approaching translation, with virus-like particle-based vaccines and CRISPR-enhanced antimicrobial phages in clinical trials. Finally, we preview emerging opportunities, including AI‑guided capsid and receptor‑binding protein design, cell‑free phage synthesis, and standardized 'reference' phage chassis that can be combined with traditional nanoparticles, positioning phage nanoparticles as reusable, plug-and-play nanomedicines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Natural Sciences, Macquarie University, Sydney, NSW 2109, Australia.
- School of Natural Sciences, Macquarie University, Sydney, NSW 2109, Australia; ARC Centre of Excellence in Synthetic Biology, Macquarie University, Sydney, Australia.
- School of Natural Sciences, Macquarie University, Sydney, NSW 2109, Australia; Australian Research Council Industrial Transformation Training Centre for Facilitated, Advancement of Australia's Bioactives (FAAB), Sydney,…
- School of Natural Sciences, Macquarie University, Sydney, NSW 2109, Australia; ARC Centre of Excellence in Synthetic Biology, Macquarie University, Sydney, Australia. Electronic address: paul.jaschke@mq.edu.au.
Förderung
- National Health and Medical Research Council
Zitieren
APA
Whiley, L., Zhu, H. X., Garcia-Bennett, A. E., & Jaschke, P. R. (2026). Bacteriophage nanoparticles: an emerging modular delivery platform. Current Opinion in Biotechnology. https://doi.org/10.1016/j.copbio.2026.103527
Vancouver
Whiley L, Zhu HX, Garcia-Bennett AE, Jaschke PR. Bacteriophage nanoparticles: an emerging modular delivery platform. Current Opinion in Biotechnology. 2026. doi:10.1016/j.copbio.2026.103527
BibTeX
@article{Whiley2026,
author = {Whiley, Linzi and Zhu, Hannah X and Garcia-Bennett, Alfonso E and Jaschke, Paul R},
title = {Bacteriophage nanoparticles: an emerging modular delivery platform},
journal = {Current Opinion in Biotechnology},
year = {2026},
doi = {10.1016/j.copbio.2026.103527}
}
EUVIMED